Importantly, our major novel finding revealed that AREG is a critical mediator of BPAF-induced ER-RTK crosstalk and is essential for the cancer-promoting effects of BPAF in our in vitro cell line models of ER+ breast cancer. Here, AREG is linked to cancer.